US 10278976
Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumors
granted A61KA61K31/085A61K31/135
Quick answer
US patent 10278976 (Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumors) held by MIRA DX, INC. expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRA DX, INC.
- Grant date
- Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/085, A61K31/135, A61K31/138, A61K31/40